PART I . Overview Invivyd, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. We are devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2, the virus that causes COVID-19. PEMGARDA (pemivibart) is our first mAb to receive regulatory authorization and was designed to exert continuous pharmaceutical a...
Q2 FY2026 — expected 2026-09-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-05 | 2025-12-31 | 0001193125-26-092547 | EDGAR | 127K words |
| 2025-03-20 | 2024-12-31 | 0000950170-25-042332 | EDGAR | — |
| 2024-03-28 | 2023-12-31 | 0000950170-24-037610 | EDGAR | — |
| 2023-03-23 | 2022-12-31 | 0000950170-23-009516 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0000950170-22-005112 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001193125-25-268076 | EDGAR | 35K words |
| 2025-08-14 | 2025-06-30 | 0000950170-25-109029 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0000950170-25-071974 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0000950170-24-126735 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0000950170-24-096674 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0000950170-24-057017 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0000950170-23-062043 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0000950170-23-041352 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0000950170-23-021235 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024516 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0000950170-22-017242 | EDGAR | — |
| 2022-05-13 | 2022-03-31 | 0000950170-22-009799 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-24 | 0001193125-26-316066 | EDGAR | — |
| 2026-03-05 | 0001193125-26-092528 | EDGAR | 5K words |
| 2026-01-08 | 0001193125-26-006997 | EDGAR | — |
| 2025-12-23 | 0001193125-25-329488 | EDGAR | — |
| 2025-11-24 | 0001193125-25-291992 | EDGAR | — |
| 2025-11-19 | 0001193125-25-288347 | EDGAR | — |
| 2025-11-06 | 0001193125-25-268057 | EDGAR | — |
| 2025-10-30 | 0001193125-25-258526 | EDGAR | — |
| 2025-10-06 | 0001193125-25-230898 | EDGAR | — |
| 2025-09-24 | 0001193125-25-215541 | EDGAR | — |
130 total filings indexed. 103 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001832038 |
| Ticker | IVVD |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.invivyd.com |
| Listed | 2021-08-06 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/IVVD (~200 tokens, structured JSON with cryptographic provenance)